Inheritance and perinatal consequences of inherited thrombophilia in Greece

International Journal of Gynecology and Obstetrics

Volumn 100, Issue 2, 2008, Pages 124-129

  Karakantza, Marina ^a   Androutsopoulos, Georgios ^a   Mougiou, Athina ^a   Sakellaropoulos, Georgios ^a   Kourounis, Georgios ^a   Decavalas, Georgios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Adverse pregnancy outcome; Complications; Factor II G20210A; Factor V Leiden; MTHFR C677T; Placental abruption

Indexed keywords

BLOOD CLOTTING FACTOR 5; CYANOCOBALAMIN; FOLIC ACID; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DEATH; FOLIC ACID BLOOD LEVEL; GENE MUTATION; GENOTYPE; GREECE; HETEROZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PERINATAL CARE; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; THROMBOPHILIA; VITAMIN BLOOD LEVEL; WOMEN'S HEALTH;

EID: 37749038746     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.08.006     Document Type: Article

References (25)

1. Pabinger I., and Vormittag R. Thrombophilia and pregnancy outcomes. Thromb Haemost 3 (2005) 1603-1610
2. Kupferminc M.J. Thrombophilia and preeclampsia: the evidence so far. Clin Obstet Gynecol 48 (2005) 406-415
3. Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D., et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132 (2006) 171-196
4. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340 (1999) 9-13
5. Infante-Rivard C., Rivard G.E., Yotov W.V., Genin E., Guiguet M., Weinberg C., et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 347 (2002) 19-25
6. Alfirevic Z., Roberts D., and Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101 (2002) 6-14
7. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
8. Nelen W.L., van der Molen E.F., Blom H.J., Heil S.G., Steegers E.A., and Eskes T.K. Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism. Br J Hosp Med 58 (1997) 511-513
9. Nurk E., Tell G.S., Refsum H., Ueland P.M., and Vollset S.E. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med 117 (2004) 26-31
10. de Vries J.I., Dekker G.A., Huijgens P.C., Jakobs C., Blomberg B.M., and van Geijn H.P. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 104 (1997) 1248-1254
11. Wouters M.G., Boers G.H., Blom H.J., Trijbels F.J., Thomas C.M., Borm G.F., et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 60 (1993) 820-825
12. Ray J.G., and Laskin C.A. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 20 (1999) 519-529
13. Cunningham G., Leveno K., Bloom S., Hauth J., Gilstrap III L., and Wenstrom K. Williams Obstetrics. 22nd ed. (2005), McGraw Hill, New York 811
14. Seeds J.W. Impaired fetal growth: definition and clinical diagnosis. Obstet Gynecol 64 (1984) 303-310
15. Cunningham G., Leveno K., Bloom S., Hauth J., Gilstrap III L., and Wenstrom K. Williams Obstetrics. 22nd ed. (2005), McGraw Hill, New York 762
16. Antoniadi T., Hatzis T., Kroupis C., Economou-Petersen E., and Petersen M.B. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 61 (1999) 265-267
17. Rees D.C., Cox M., and Clegg J.B. World distribution of factor V Leiden. Lancet 346 (1995) 1133-1134
18. Rosendaal F.R., Doggen C.J., Zivelin A., Arruda V.R., Aiach M., Siscovick D.S., et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 79 (1998) 706-708
19. Pepe G., Camacho Vanegas O., Giusti B., Brunelli T., Marcucci R., Attanasio M., et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet 63 (1998) 917-920
20. Goddijn-Wessel T.A., Wouters M.G., van de Molen E.F., Spuijbroek M.D., Steegers-Theunissen R.P., Blom H.J., et al. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 66 (1996) 23-29
21. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82 (2005) 806-812
22. Baker H., Frank O., Deangelis B., Feingold S., and Kaminetzky H.A. Role of placenta in maternal-fetal vitamin transfer in humans. Am J Obstet Gynecol 141 (1981) 792-796
23. Salomon O., Seligsohn U., Steinberg D.M., Zalel Y., Lerner A., Rosenberg N., et al. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol 191 (2004) 2002-2009
24. Brenner B. Thrombophilia and pregnancy loss. Thromb Res 108 (2002) 197-202
25. Kim Y.J., Williamson R.A., Murray J.C., Andrews J., Pietscher J.J., Peraud P.J., et al. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 184 (2001) 1211-1217